Loading provider…
Loading provider…
Surgery Physician in Winston Salem, NC
NPI: 1275518334Primary Practice Location
NORTH CAROLINA BAPTIST HOSPITAL
Medical Center Blvd, Winston Salem, NC
Primary Employer
Wake Forest University Health Sciences
wakehealth.edu
HQ Phone
Get MD Edward's Phone Numberphone_androidMobile
Get MD Edward's MobileLooking to connect with more Physicians?
Dmand AI gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Get Started for Freearrow_outwardNC State Medical License
| # | Procedure Code (CPT®/HCPCS II) | Procedure Patients | Procedure Volume |
|---|---|---|---|
| 1 | 99213Established patient office or other outpatient visit, typically 15 minutes | 97 | 117 |
| 2 | 99205New patient office or other outpatient visit, typically 60 minutes | 42 | 42 |
| 3 | 99214Established patient office or other outpatient visit, 30-39 minutes | 29 | 37 |
| 4 | 99204New patient office or other outpatient visit, 45-59 minutes | 19 | 19 |
| 5 | 19301Partial removal of breast | 11 | 11 |
Management of Cancer Surgery Cases During the COVID-19 Pandemic: Considerations.
Authors: Carmen Solorzano, Vance Sohn, George Chang, Anthony Yang, Aimee Crago, Sam Yoon, David Bartlett, Eleftherios Mamounas, Nipun Merchant, Melissa Hogg, Giorgos Karakousis, Ajay Maker
Journal: Ann Surg Oncol
Publication Date: 2020-04-08
Early- and long-term outcome data of patients with pseudomyxoma peritonei from appendiceal origin treated by a strategy of cytoreductive surgery and hyperthermic intraperitoneal chemotherapy.
Authors: Paul Sugarbaker, Armando Sardi
Publication Date: 2012-05-23
Patient rated outcomes and survivorship following cytoreductive surgery plus hyperthermic intraperitoneal chemotherapy (CS + HIPEC).
Authors: Katharine Duckworth, Richard Mcquellon, Gregory Russell, Craig Cashwell, Perry Shen, John Stewart, Edward Levine
Publication Date: 2011-11-14
Lead Sponsor: National Cancer Institute (NCI)
Intervention / Treatment: OTHER: Laboratory Biomarker Analysis
Lead Sponsor: Dan Blazer III, M.D.
Intervention / Treatment: BIOLOGICAL: Talimogene Laherparepvec
Lead Sponsor: OncoNano Medicine, Inc.
Intervention / Treatment: DRUG: pegsitacianine